Skip to content
healthcare.dev

Selegiline Hydrochloride

NDC 10135-737, Selegiline Hydrochloride, capsule, from Marlex Pharmaceuticals, Inc..

Product NDC
10135-737
Status
Listed
Labeler
Marlex Pharmaceuticals, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075352
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-737 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SELEGILINE HYDROCHLORIDE5 mg/1

Pharmacologic classes

Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]; Monoamine Oxidase Type B Inhibitor [EPC]; Monoamine Oxidase-B Inhibitors [MoA]

Package NDCNDC-11Package
10135-737-601013507376060 CAPSULE in 1 BOTTLE (10135-737-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/df88d6bf-0fda-3825-e053-2a95a90a3a75

Use it

Look up 10135-737 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-737 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-737. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.